Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$144.38 - $157.78 $721 - $788
5 Added 0.22%
2,312 $337,000
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $155 - $162
-1 Reduced 0.04%
2,307 $364,000
Q4 2023

Jan 24, 2024

SELL
$145.6 - $158.88 $3,494 - $3,813
-24 Reduced 1.03%
2,308 $361,000
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $5,918 - $6,630
-38 Reduced 1.6%
2,332 $363,000
Q2 2023

Jul 21, 2023

SELL
$154.35 - $166.11 $84,892 - $91,360
-550 Reduced 18.84%
2,370 $392,000
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $3,474 - $4,145
23 Added 0.79%
2,920 $452,000
Q4 2022

Feb 01, 2023

BUY
$160.2 - $179.79 $8,650 - $9,708
54 Added 1.9%
2,897 $511,000
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $137,453 - $152,951
-852 Reduced 23.06%
2,843 $464,000
Q2 2022

Sep 23, 2022

BUY
$168.19 - $186.01 $621,462 - $687,306
3,695 New
3,695 $655,000
Q2 2022

Aug 02, 2022

SELL
$168.19 - $186.01 $619,107 - $684,702
-3,681 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $5,693 - $6,465
-36 Reduced 0.97%
3,681 $652,000
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $4,833 - $5,363
-31 Reduced 0.83%
3,717 $635,000
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $646 - $717
4 Added 0.11%
3,748 $604,000
Q2 2021

Aug 02, 2021

BUY
$159.48 - $171.07 $18,180 - $19,501
114 Added 3.14%
3,744 $624,000
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $7,347 - $8,183
48 Added 1.34%
3,630 $596,000
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $19,469 - $22,347
142 Added 4.13%
3,582 $578,000
Q3 2020

Oct 26, 2020

BUY
$140.38 - $153.83 $170,140 - $186,441
1,212 Added 54.4%
3,440 $512,000
Q2 2020

Aug 03, 2020

SELL
$128.81 - $155.51 $572,045 - $690,619
-4,441 Reduced 66.59%
2,228 $313,000
Q1 2020

Apr 28, 2020

BUY
$111.14 - $153.99 $333 - $461
3 Added 0.05%
6,669 $874,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $849,915 - $976,169
6,666 New
6,666 $992,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capital Wealth Alliance, LLC Portfolio

Follow Capital Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Alliance, LLC with notifications on news.